Studies on novel HIF activators, A-503451sII: biological activities of A-503451A

J Antibiot (Tokyo). 2016 Oct;69(10):754-758. doi: 10.1038/ja.2016.20. Epub 2016 Mar 9.

Abstract

In the course of our screening, we discovered a novel compound, A-503451A, as a potent hypoxia-inducible factor (HIF) activator. In human hepatocarcinoma HepG2 cells, A-503451A induced HIF-mediated luciferase reporter gene expression and stabilized HIF-1α protein. A-503451A increased the mRNA expression levels and the protein secretion of HIF-dependent genes, vascular endothelial growth factor and erythropoietin. Addition of excess ferric chloride to the culture medium suppressed the HIF-induction activity of A-503451A. A-503451A did not have iron-chelating activity in vitro, but decreased the intracellular labile iron pool concentration. These data indicate that A-503451A is a unique HIF activator.

MeSH terms

  • Culture Media / chemistry
  • Erythropoietin / genetics
  • Erythropoietin / metabolism
  • Fermentation
  • Gene Expression Regulation
  • Genes, Reporter
  • Hep G2 Cells
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / agonists*
  • Indoles / chemistry
  • Indoles / pharmacology*
  • Iron Chelating Agents / chemistry
  • Iron Chelating Agents / pharmacology*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • A-503451A
  • Culture Media
  • EPO protein, human
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Indoles
  • Iron Chelating Agents
  • RNA, Messenger
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Erythropoietin